{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03818",
    "Peptide Name": "Aquiluscidin (Aq-CATH; Lys-rich; natural AMPs; cathelicidins; Rattlesnake, reptiles, animals, XXA, UCLL1c)",
    "Source": "skin; oral mucosa, the Querétaro’s dark rattlesnake,Crotalus aquilus",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KRFKKFFKKVKKSVKKRLKKIFKKPMVIGVSFPF",
    "Sequence Length": 34,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 16,
    "Boman Index": 1.66,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "41%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is most similar (94.12%) torattlesnake Crotalicidin.   K: 38%; V: 12%, F: 18%. GRAVY: -0.48; M Wt: 4172.316; M formula:  C205H341N53O37S1, mol ex coeff: 0.Activity: active against E. coli TOP10 or clinical strain (MIC 0.47 uM), S. aureus ATCC6538 or clinical strain (MIC 1.91 uM), P. aeruginosa or clinical strain (MIC 0.95 uM), S. saprophyticus ATCC BAA-750 (MIC 0.95 uM), S. typhymurium ATCC 14028 (MIC 1.91 uM), and  E. casseliflavus ATCC 700327 (MIC 0.95 uM).parasites: Aquiluscidin inhibited B. ovata (IC50 14.48 uM) and B. bovis (IC50 20.7 uM). Activity is serum-sensitive:parasites  (Hernández-Arvizu et al., 2024).Toxicity: rat RBC: less than 3% hemolysis at 50 uM (incubated 30 min). HEK293 cells (IC50 ~35 uM).Structure:  predicted to be amphipathic helix.Updated 6/2024",
    "Author": "Hernández-Arvizu, E.E.; Silis-Moreno, T.M.; GarcíaArredondo, J.A.; Rodríguez-Torres, A.; Cervantes-Chávez, J.A.; Mosqueda, J. 2023",
    "Reference": "Microorganisms 2023; 11: 2778. https://doi.org/10.3390/microorganisms11112778.Publisher",
    "Title": "Aquiluscidin, a Cathelicidin from Crotalus aquilus, and the Vcn-23 Derivative Peptide, Have Anti-Microbial Activity against Gram-Negative and Gram-Positive Bacteria"
  },
  "3D Structure": []
}